Table 2.
Malignant lesions | n | Benign lesions | n |
---|---|---|---|
Invasive carcinoma NST | 53 (81.6%) | Fibroadenoma | 24 (40.7%) |
Invasive lobular carcinoma | 6 (9.2%) | Fibroadenomatous hyperplasia | 8 (13.6%) |
Ductal carcinoma in situ | 4 (6.2%) | Papilloma | 5 (8.5%) |
Mucinous carcinoma | 1 (1.5%) | Fibrosis | 4 (6.7%) |
Neuroendocrine carcinoma | 1 (1.5%) | Others | 18 (30.5%) |
NST: no special type.